Arvind Remedies Ltd

Arvind Remedies Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Arvind Remedies Ltd

₹ 4.70 -4.86%
13 Jun 2016
arvindremedies.com BSE: 531823
About

Arvind Remedies (ARL) engages in the drugs and pharmaceuticals business of India that manufactures capsules, liquids, ointments, tablets Syrup, Cream & Powders as well as Ayurvedic products at Kancheepuram in Tamilnadu.

[ add key points ]
Website BSE
  • Market Cap ₹ 31.7 Cr.
  • Current Price ₹ 4.70
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -22.5
  • Dividend Yield 0.00 %
  • ROCE -8.56 %
  • ROE -114 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of -6.73% over last 3 years.
  • Company has high debtors of 221 days.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016
184 220 233 274 259 293 176 47 12 6 2 2 1
144 182 187 222 195 251 197 172 14 6 2 98 2
Operating Profit 40 38 46 53 63 42 -21 -126 -2 1 0 -95 -0
OPM % 22% 17% 20% 19% 25% 14% -12% -269% -14% 10% 1% -3,881% -21%
0 0 0 0 0 0 -115 -67 0 0 0 4 -20
Interest 16 17 18 26 24 33 22 -5 -4 1 0 0 0
Depreciation 3 3 3 4 7 6 7 4 6 6 1 7 6
Profit before tax 21 18 25 23 33 2 -165 -191 -4 -6 -2 -99 -26
Tax % 23% 26% 24% 53% 20% 40% -0% -3% 0% 0% 0% 0% 0%
17 13 19 11 26 1 -165 -185 -4 -6 -2 -99 -26
EPS in Rs 0.34 1.93 2.73 1.56 3.83 0.19 -24.18 -27.19 -0.62 -0.89 -0.22 -14.55 -3.82
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Jun 2015 15m TTM
144 157 176 218 298 363 437 664 911 787 12
133 143 160 198 267 321 369 531 734 842 107
Operating Profit 11 14 16 20 31 41 68 134 177 -55 -95
OPM % 7% 9% 9% 9% 10% 11% 16% 20% 19% -7% -777%
1 0 0 1 1 0 0 1 1 -170 -16
Interest 5 7 7 11 14 16 28 59 77 71 1
Depreciation 2 2 2 2 2 2 3 13 14 29 20
Profit before tax 5 5 7 7 15 23 37 63 86 -325 -133
Tax % 39% 20% 26% 33% 31% 26% 48% 35% 32% -2%
3 4 5 5 11 17 19 41 59 -320 -133
EPS in Rs 0.35 0.40 0.84 8.65 -46.98 -19.48
Dividend Payout % 42% 30% 25% 27% 12% 20% 17% 12% 9% 0%
Compounded Sales Growth
10 Years: %
5 Years: 21%
3 Years: 22%
TTM: -98%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 32%
Stock Price CAGR
10 Years: -10%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 0%
3 Years: -7%
Last Year: -114%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Jun 2015
Equity Capital 26 26 26 26 26 48 48 48 68 68
Reserves 12 15 19 22 69 73 95 146 211 -110
57 85 86 104 123 184 362 520 623 750
22 31 42 40 50 65 98 128 189 77
Total Liabilities 117 158 173 192 268 370 603 842 1,092 784
26 29 30 35 36 45 242 251 349 275
CWIP 5 27 35 20 38 19 49 37 67 0
Investments 0 0 0 0 0 0 3 3 6 3
86 102 108 138 194 306 309 551 670 505
Total Assets 117 158 173 192 268 370 603 842 1,092 784

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Jun 2015
-9 10 16 -13 -8 12 7 13 -60 -151
-7 -27 -12 8 -21 -62 -158 -123 -21 105
7 20 -8 5 42 55 152 112 63 44
Net Cash Flow -9 4 -3 -0 13 6 1 2 -18 -2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Jun 2015
Debtor Days 135 152 143 140 131 135 142 133 133 221
Inventory Days 66 75 78 65 66 68 92 89 104 3
Days Payable 23 47 69 50 48 49 40 49 50 4
Cash Conversion Cycle 178 179 152 155 149 155 194 173 187 221
Working Capital Days 178 170 149 176 171 162 174 177 206 214
ROCE % 11% 11% 13% 16% 15% 16% 20% 20% -9%

Shareholding Pattern

Numbers in percentages

Mar 2016Jun 2016
3.58% 3.58%
0.02% 0.02%
96.41% 96.41%
No. of Shareholders 71,27771,277

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings